Acyclovir Sodium



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 45.7%
Herpes Zoster 9.8%
Drug Use For Unknown Indication 9.2%
Encephalitis Herpes 3.3%
Genital Herpes 3.3%
Herpes Virus Infection 3.3%
Encephalitis 2.7%
Neuroblastoma 2.7%
Pain 2.7%
Herpes Simplex 2.2%
Oral Herpes 2.2%
Acne 1.6%
Epilepsy 1.6%
Glioblastoma Multiforme 1.6%
Multiple Myeloma 1.6%
Prophylaxis 1.6%
Ulcer 1.6%
Apparent Life Threatening Event 1.1%
Encephalitis Brain Stem 1.1%
Hiv Infection 1.1%
Drug Ineffective 17.7%
Vomiting 11.3%
Venoocclusive Liver Disease 8.1%
Renal Failure Acute 6.5%
Visual Acuity Reduced 6.5%
Herpes Zoster 4.8%
Psychiatric Symptom 4.8%
Rash 4.8%
Vulvitis 4.8%
Alopecia 3.2%
Drug Hypersensitivity 3.2%
Herpes Virus Infection 3.2%
Live Birth 3.2%
Malaise 3.2%
Therapeutic Response Unexpected 3.2%
Urticaria 3.2%
White Blood Cell Count Decreased 3.2%
Ataxia 1.6%
Atrial Fibrillation 1.6%
Azotaemia 1.6%
Secondary
Drug Use For Unknown Indication 14.4%
Antiviral Prophylaxis 12.9%
Herpes Zoster 8.5%
Product Used For Unknown Indication 8.5%
Prophylaxis Against Transplant Rejection 8.2%
Prophylaxis 6.5%
Pain 4.4%
Antibiotic Prophylaxis 3.8%
Glioblastoma Multiforme 3.5%
Histiocytosis Haematophagic 3.5%
Burkitt's Lymphoma 3.2%
Antifungal Prophylaxis 2.6%
Diffuse Large B-cell Lymphoma 2.6%
Hiv Infection 2.6%
Multiple Myeloma 2.6%
Procedural Pain 2.6%
Thrombosis Prophylaxis 2.6%
Mycobacterium Avium Complex Infection 2.4%
Hypertension 2.1%
Infection Prophylaxis 2.1%
Drug Ineffective 18.5%
Venoocclusive Liver Disease 15.4%
Renal Failure 9.2%
Death 4.6%
Dilatation Intrahepatic Duct Acquired 4.6%
Rash 4.6%
Renal Failure Acute 4.6%
Torsade De Pointes 4.6%
Vomiting 4.6%
Dysgeusia 3.1%
Febrile Neutropenia 3.1%
Herpes Zoster 3.1%
Pregnancy 3.1%
Pyrexia 3.1%
Thrombocytopenia 3.1%
Toxic Epidermal Necrolysis 3.1%
Treatment Failure 3.1%
Alopecia 1.5%
Bacteraemia 1.5%
Bradycardia 1.5%
Concomitant
Product Used For Unknown Indication 30.1%
Drug Use For Unknown Indication 12.9%
Prophylaxis 8.3%
Multiple Myeloma 6.6%
Pain 4.5%
Infection Prophylaxis 4.3%
Hiv Infection 3.8%
Acute Myeloid Leukaemia 3.4%
Chronic Lymphocytic Leukaemia 3.4%
Non-hodgkin's Lymphoma 3.4%
Antiviral Prophylaxis 2.6%
Prophylaxis Against Graft Versus Host Disease 2.5%
Premedication 2.3%
Diffuse Large B-cell Lymphoma 1.9%
Depression 1.9%
Hypertension 1.8%
Antifungal Prophylaxis 1.6%
Rheumatoid Arthritis 1.6%
Bone Marrow Conditioning Regimen 1.4%
Herpes Zoster 1.4%
Vomiting 11.7%
White Blood Cell Count Decreased 11.7%
Pyrexia 9.5%
Thrombocytopenia 9.2%
Weight Decreased 7.8%
Pneumonia 5.3%
Sepsis 4.6%
Tremor 4.6%
Urinary Tract Infection 4.2%
Neutropenic Sepsis 3.2%
Pruritus 3.2%
Renal Failure Acute 3.2%
Wheezing 3.2%
Febrile Neutropenia 2.8%
Inappropriate Antidiuretic Hormone Secretion 2.8%
Respiratory Failure 2.8%
Stevens-johnson Syndrome 2.8%
Pleural Effusion 2.5%
Septic Shock 2.5%
Somnolence 2.5%
Interacting
Product Used For Unknown Indication 86.4%
Acute Promyelocytic Leukaemia 4.5%
Herpes Zoster 4.5%
Type 2 Diabetes Mellitus 4.5%
Drug Interaction 50.0%
Hypoglycaemia 50.0%